This case-to-case variation and weaker correlation of MYC and γH2AX levels in lymphomas, as compared to hemangiosarcomas, paralleled greater variation in overall RNA, protein, and DNA status (genome rearrangements, etc.)(see Figure 5). The gene discussed is MYC; the disease is angiosarcoma.